| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |